HDAC2 deficiency sensitizes colon cancer cells to TNFα-induced apoptosis through inhibition of NF-κB activity
- 15 April 2008
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 314 (7), 1507-1518
- https://doi.org/10.1016/j.yexcr.2008.01.010
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine ResidueScience, 2005
- The Mechanism of the Anti-Tumor Activity of the Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA)Cell Cycle, 2004
- Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaBThe EMBO Journal, 2002
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokinesProceedings of the National Academy of Sciences, 2002
- Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome ActivityJournal of Biological Chemistry, 2001
- The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene ExpressionMolecular and Cellular Biology, 2001
- Therapeutic Targeting of Transcription in Acute Promyelocytic Leukemia by Use of an Inhibitor of Histone DeacetylaseJNCI Journal of the National Cancer Institute, 1998
- A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegansGenes & Development, 1998
- Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal DomainCell, 1997